NCT00195091 2025-05-16
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
Clinical Trials
4 trialsNCT00176800 2016-08-22
Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00150995 2015-01-21
Tetrathiomolybdate in Hormone Refractory Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00176774 2012-02-07
Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma
University of Michigan Rogel Cancer Center
Phase 2 Completed